Video Experimental Relacionado
Updated: Sep 9, 2025
10:06
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
9.0K
H3K18la facilita la escisión alternativa mediada por TRA2A de STIL, suprimiendo la ferroptosis y la sensibilidad al
Mingyang Gao1, Shiming Wang2, Zhiyuan Huang3
1General Hospital of Northern Theater Command, Shenyang, China.
Cancer research and treatment
|September 4, 2025
Resumen
Las células de cáncer de ovario evitan la muerte celular a través de una vía de señalización TRA2A-STIL, impulsada por la lactilación de histonas. Dirigirse a esta vía aumenta la efectividad de la quimioterapia, ofreciendo una nueva estrategia terapéutica para el cáncer de ovario.
Área de la Ciencia:
- En el campo de la oncología
- Biología molecular
- La epigenética
Sus antecedentes:
- El cáncer de ovario (CO) presenta desafíos significativos debido al diagnóstico tardío y la quimiorresistencia.
- La comprensión de los mecanismos de desarrollo de la OC y la identificación de nuevos objetivos terapéuticos son fundamentales.
Objetivo del estudio:
- Para aclarar el papel de TRA2A y la lactilación de histonas en la progresión de OC.
- Identificar nuevos objetivos terapéuticos para la superación de la quimiorresistencia OC.
Principales métodos:
- Análisis bioinformático, qRT-PCR, Western Blot (WB) y inmunohistoquímica (IHC) para el TRA2A y la lactilación de histonas.
- Los ensayos de proliferación celular (CCK8, formación de clones, EdU) y los ensayos de Transwell.
- RT-PCR para el análisis de empalme alternativo y la validación in vivo utilizando un modelo de xenotransplante de ratón desnudo.
Principales resultados:
- Se identificó un nuevo mecanismo de evasión de la ferroposis OC a través del eje de señalización TRA2A-STIL.
- La lactilación de histonas (H3K18la) promueve la transcripción de TRA2A, lo que lleva al empalme alternativo del ARNm STIL y a la isoforma STIL-L.
- La reducción dirigida de TRA2A combinada con cisplatino aumentó la eficacia del tratamiento con OC.
Conclusiones:
- Las células OC evaden la ferroposis a través de un eje de señalización TRA2A-STIL modificado por H3K18la.
- La orientación al empalme alternativo mediado por TRA2A presenta una estrategia terapéutica prometedora para el cáncer de ovario.
Palabras clave:
El empalme alternativoLa ferroposisH3K18la y sus derivadosNeoplasia de los ovariosTRA2A (en inglés)Más Videos Relacionados
Videos de Conceptos Relacionados
02:18Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
01:32RNA Splicing
56.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.9K
02:39lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
02:41Chromatin Structure Regulates pre-mRNA Processing
7.2K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
7.2K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K